Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,960.00p
   
  • Change Today:
      35.00p
  • 52 Week High: 2,205.00
  • 52 Week Low: 1,722.00
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 299,387
  • Market Cap: £4,348.95m
  • RiskGrade: 125

Hikma upgrades FY guidance, cautious on Sudan impact

By Frank Prenesti

Date: Friday 28 Apr 2023

LONDON (ShareCast) - (Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance after a stronger-than-expected start to the year for its generics business but expressed concern about the impact of the current conflict in Sudan on operations.
"The safety and wellbeing of our colleagues in Sudan is a top priority and we are doing what we can to support them. Our current guidance does not take into account any potential impact this evolving situation could have on our business. In 2022 sales from Sudan in our branded and injectables businesses represented 2.5% of group revenue," the company said on Friday.

"We have also had a stronger than expected start in our generics business, leading us to upgrade our guidance for the full year."

Reporting by Frank Prenesti for Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,960.00p
Change Today 35.00p
% Change 1.82 %
52 Week High 2,205.00
52 Week Low 1,722.00
Volume 299,387
Shares Issued 221.89m
Market Cap £4,348.95m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.81% below the market average51.81% below the market average51.81% below the market average51.81% below the market average51.81% below the market average
45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average
Price Trend
49.31% above the market average49.31% above the market average49.31% above the market average49.31% above the market average49.31% above the market average
67.27% above the sector average67.27% above the sector average67.27% above the sector average67.27% above the sector average67.27% above the sector average
Income
9.05% above the market average9.05% above the market average9.05% above the market average9.05% above the market average9.05% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
37.88% below the market average37.88% below the market average37.88% below the market average37.88% below the market average37.88% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 21-Mar-24 10-Aug-23
Paid 03-May-24 15-Sep-23
Amount 47.00¢ 25.00¢

Trades for 03-May-2024

Time Volume / Share Price
16:35 169,283 @ 1,960.00p
16:35 9 @ 1,960.00p
16:35 445 @ 1,960.00p
16:35 2,056 @ 1,960.00p
16:35 410 @ 1,960.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page